- Report
- October 2024
- 182 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 197 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 195 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 180 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 195 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 199 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- December 2024
- 150 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- March 2025
- 294 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- February 2025
- 150 Pages
Global
From €4425EUR$4,850USD£3,805GBP
- Report
- February 2025
- 150 Pages
Global
From €4425EUR$4,850USD£3,805GBP
- Report
- February 2025
- 150 Pages
Global
From €4425EUR$4,850USD£3,805GBP
- Report
- October 2024
- 200 Pages
Global
From €4515EUR$4,949USD£3,883GBP
- Report
- March 2025
- 180 Pages
Global
From €4105EUR$4,500USD£3,531GBP
- Report
- June 2024
- 183 Pages
Global
From €4105EUR$4,500USD£3,531GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3530EUR$3,869USD£3,035GBP
- Report
- December 2022
- 78 Pages
Global
From €5018EUR$5,500USD£4,315GBP
- Report
- April 2024
- 138 Pages
Global
From €2736EUR$2,999USD£2,353GBP

The Oral Vaccine market is a subset of the larger Vaccines market, which is focused on the development and distribution of vaccines to prevent and treat infectious diseases. Oral Vaccines are administered orally, rather than through injection, and are typically used to protect against gastrointestinal infections. These vaccines are often used in developing countries, where access to injection-based vaccines may be limited. Oral Vaccines are also used in certain circumstances where injection-based vaccines may not be suitable, such as in the elderly or immunocompromised individuals.
Oral Vaccines are typically composed of weakened or killed pathogens, which stimulate the body’s immune system to produce antibodies against the disease. These vaccines are typically administered in multiple doses, and may require booster shots to maintain immunity.
Some companies in the Oral Vaccine market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more